Treatment recommendations are made following professional clinical judgement, with patient safety and best practice at the core
Westersthl, M., Jansson, E., & Aasa, U
Therapy of the rat hemorrhagic cystitis induced by cyclophosphamide
GHK-Cu (50mg) + BPC-157 (10mg) + TB-500 (10mg) + KPV (10mg) All products are for laboratory research purposes only
This therapy is often considered when: Metabolic support is needed alongside lifestyle adjustments Energy levels are a concern during wellness or weight-management efforts A provider-directed injectable option is preferred Ongoing clinical monitoring is important Men receiving care at our Huntington Beach clinic are evaluated individually to ensure MIC Lipotropic + B12 injections align with overall care goals
Gastrointestinal disorders - Abdominal discomfort, dyspepsia, diarrhoea, vomiting, nausea, dysphagia